AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2015
Feb 5, 2015
34117_dirs_2015-02-05_af162da5-aa66-455b-92dd-70cd642e0372.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2015-02-05
Reporting Person: Fox Dale (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-05 | Employee Stock Option | $0.25 | D | 150000 | Disposed | 2024-08-08 | Common Stock (150000) | Direct |
| 2015-02-05 | Employee Stock Option | $0.103 | A | 150000 | Acquired | 2024-08-08 | Common Stock (150000) | Direct |
| 2015-02-05 | Employee Stock Option | $0.112 | D | 300000 | Disposed | 2025-01-02 | Common Stock (300000) | Direct |
| 2015-02-05 | Employee Stock Option | $0.103 | A | 300000 | Acquired | 2025-01-02 | Common Stock (300000) | Direct |
Footnotes
F1: Each of the transactions reported in this Form 4 involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the "old" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6